Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ABBV

AbbVie (ABBV)

AbbVie Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ABBV
DateTimeSourceHeadlineSymbolCompany
06/10/20208:15AMPR Newswire (US)Novel Antibody Drug Conjugate ABBV-3373 Shows Improvement in Disease Activity in Phase 2a Study of Patients with Rheumatoid A...NYSE:ABBVAbbVie Inc
06/10/20206:00AMPR Newswire (US)AbbVie and Genmab Announce Broad Oncology CollaborationNYSE:ABBVAbbVie Inc
06/06/20208:30AMPR Newswire (US)AbbVie Presents Data Showing RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study...NYSE:ABBVAbbVie Inc
06/05/20206:00AMBusiness WireAbbVie, Harbour BioMed, Utrecht University & Erasmus Medical Center Announce Collaboration to Develop Monoclonal Antibody The...NYSE:ABBVAbbVie Inc
06/05/20206:00AMPR Newswire (US)AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Announce Collaboration to Develop Monoclonal Antibody T...NYSE:ABBVAbbVie Inc
06/04/20208:30AMPR Newswire (US)New Long-term Data from RINVOQ™ (upadacitinib, 15 mg) Phase 3 Studies in Rheumatoid Arthritis Presented at 2020 Annual Euro...NYSE:ABBVAbbVie Inc
06/04/20207:00AMPR Newswire (US)Dr. Keshav K. Singh Joins Allergan Aesthetics Science Of Aging(SM) FacultyNYSE:ABBVAbbVie Inc
06/03/20208:00AMPR Newswire (US)AbbVie to Present at the Virtual Goldman Sachs 41st Annual Global Healthcare ConferenceNYSE:ABBVAbbVie Inc
06/01/20205:02PMEdgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:ABBVAbbVie Inc
06/01/202011:40AMPR Newswire (US)AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Ps...NYSE:ABBVAbbVie Inc
06/01/20208:30AMPR Newswire (US)Allergan Aesthetics Launches Dedicated Multi-Channel Campaign To Contact Patients Who May Not Be Aware Of The BIOCELL® Recal...NYSE:ABBVAbbVie Inc
06/01/20201:00AMPR Newswire (US)AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 InhibitorsNYSE:ABBVAbbVie Inc
05/29/20204:14PMPR Newswire (US)FDA Approves the First Oral Medication for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopaus...NYSE:ABBVAbbVie Inc
05/27/20208:50AMDow Jones NewsShares of Ironwood Move Lower Premarket After Study Fails To Meet GoalsNYSE:ABBVAbbVie Inc
05/27/20208:30AMPR Newswire (US)AbbVie Presents New Data at the European E-Congress of Rheumatology (EULAR) 2020 Showcasing Depth of its Rheumatology Portfol...NYSE:ABBVAbbVie Inc
05/22/20205:48PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NYSE:ABBVAbbVie Inc
05/22/20205:46PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NYSE:ABBVAbbVie Inc
05/21/20208:43AMDow Jones NewsSynlogic Shares Fall as AbbVie Collaboration EndsNYSE:ABBVAbbVie Inc
05/15/20204:39PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NYSE:ABBVAbbVie Inc
05/15/20208:30AMPR Newswire (US)AbbVie Data at EHA Annual Congress Highlight Depth and Breadth of Transformative Blood Cancer PortfolioNYSE:ABBVAbbVie Inc
05/14/20205:01PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NYSE:ABBVAbbVie Inc
05/14/20204:48PMDow Jones NewsAllergan, Ideal Implant Issued Warning Letters From FDA Related to Breast ImplantsNYSE:ABBVAbbVie Inc
05/14/20204:18PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
05/14/20208:00AMPR Newswire (US)AbbVie to Present at the UBS Virtual Healthcare ConferenceNYSE:ABBVAbbVie Inc
05/13/20208:00AMPR Newswire (US)AbbVie Announces Final Results of Exchange Offers for Allergan NotesNYSE:ABBVAbbVie Inc
05/12/20205:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
05/12/20205:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
05/12/20205:52PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NYSE:ABBVAbbVie Inc
05/12/20205:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
05/12/20205:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
 Showing the most relevant articles for your search:NYSE:ABBV